Biohaven Ltd (NYSE: BHVN) kicked off on Friday, down -8.78% from the previous trading day, before settling in for the closing price of $48.66. Over the past 52 weeks, BHVN has traded in a range of $26.80-$62.21.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
While this was happening, its average annual earnings per share was recorded -54.39%. With a float of $88.45 million, this company’s outstanding shares have now reached $100.95 million.
Let’s determine the extent of company efficiency that accounts for 239 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Biohaven Ltd (BHVN) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Biohaven Ltd is 12.09%, while institutional ownership is 86.48%. The most recent insider transaction that took place on Oct 02 ’24, was worth 999,970. In this transaction Director of this company bought 21,052 shares at a rate of $47.50, taking the stock ownership to the 21,052 shares. Before that another transaction happened on Oct 02 ’24, when Company’s Chief Executive Officer bought 21,052 for $47.50, making the entire transaction worth $999,970. This insider now owns 861,942 shares in total.
Biohaven Ltd (BHVN) Recent Fiscal highlights
In the latest quarterly report, which was put into the public domain on 9/30/2024, the organization reported -1.61 earnings per share (EPS), lower than consensus estimate (set at -1.34) by -0.27. Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.58 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -54.39% per share during the next fiscal year.
Biohaven Ltd (NYSE: BHVN) Trading Performance Indicators
Take a look at Biohaven Ltd’s (BHVN) current performance indicators. Last quarter, stock had a quick ratio of 2.89.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -9.35, a number that is poised to hit -1.61 in the next quarter and is forecasted to reach -6.31 in one year’s time.
Technical Analysis of Biohaven Ltd (BHVN)
Looking closely at Biohaven Ltd (NYSE: BHVN), its last 5-days average volume was 0.94 million, which is a drop from its year-to-date volume of 1.14 million. As of the previous 9 days, the stock’s Stochastic %D was 6.14%. Additionally, its Average True Range was 2.63.
During the past 100 days, Biohaven Ltd’s (BHVN) raw stochastic average was set at 51.25%, which indicates a significant increase from 9.80% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 49.22% in the past 14 days, which was lower than the 54.97% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $48.16, while its 200-day Moving Average is $43.76. However, in the short run, Biohaven Ltd’s stock first resistance to watch stands at $48.22. Second resistance stands at $52.05. The third major resistance level sits at $54.54. If the price goes on to break the first support level at $41.90, it is likely to go to the next support level at $39.41. Now, if the price goes above the second support level, the third support stands at $35.58.
Biohaven Ltd (NYSE: BHVN) Key Stats
The company with the Market Capitalisation of 4.09 billion has total of 101,122K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -408,170 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -319,770 K.
